Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Jul 22

PMID 35865445

Authors

Nailah Asif

Apurva Patel

Deepanjali Vedantam

Devyani S Poman

Lakshya Motwani

Affiliations

Soon will be listed here.

Abstract

Migraine is a neurological disorder that strongly relates to psychiatric conditions like depression. Lately, the increased prevalence of depression in migraineurs has come to attention. This article compiled various literature to explore the association between migraine and depression. Genetic overlap of various gene segments was studied, and heritability patterns were explored. Shared mechanisms such as serotonergic dysfunction, methylenetetrahydrofolate reductase (MTHFR) polymorphisms, and hormonal effects were investigated, and commonalities like comorbidities, stress, and environmental factors were analyzed. Migraine with comorbid depression (MID) affects various aspects of life and its clinical impact on migraine disability, quality of life (QOL), progression, and medication overuse was investigated. We further inspected several types of research in order to provide options on various treatment modalities. Pharmacotherapy such as antidepressants and anti-Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies like fremanezumab were studied. Alternative treatment options such as onabotulinumtoxinA (OBTA) injections, cognitive behavioral therapy (CBT), and vagal nerve stimulations (VNS) were also appraised and the efficacies of each were compared.

Citing Articles

Identification of genetic susceptibility for Chinese migraine with depression using machine learning.

An X, Zhao S, Fang J, Li Q, Yue C, Jing C Front Neurol. 2024; 15:1418529.

PMID: 39144710 PMC: 11322385. DOI: 10.3389/fneur.2024.1418529.

A Narrative Review of Intestinal Microbiota's Impact on Migraine with Psychopathologies.

Francavilla M, Facchetti S, Demartini C, Zanaboni A, Amoroso C, Bottiroli S Int J Mol Sci. 2024; 25(12).

PMID: 38928361 PMC: 11203823. DOI: 10.3390/ijms25126655.

Early maladaptive schemas in female patients with migraine and tension-type headache.

Yontar G, Ozgan E Sci Rep. 2024; 14(1):3550.

PMID: 38347033 PMC: 10861436. DOI: 10.1038/s41598-024-53816-4.

Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study.

Alwhaibi M, Balkhi B, AlRuthia Y Front Public Health. 2023; 11:1241800.

PMID: 37860801 PMC: 10582631. DOI: 10.3389/fpubh.2023.1241800.

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Vikelis M, Dermitzakis E, Xiromerisiou G, Rallis D, Soldatos P, Litsardopoulos P J Clin Med. 2023; 12(13).

PMID: 37445560 PMC: 10342907. DOI: 10.3390/jcm12134526.

References

Jette N, Patten S, Williams J, Becker W, Wiebe S . Comorbidity of migraine and psychiatric disorders--a national population-based study. Headache. 2007; 48(4):501-16. DOI: 10.1111/j.1526-4610.2007.00993.x. View

Louter M, Veen G, Ferrari M, Zitman F, Terwindt G . [Migraine and depression should be treated concurrently]. Ned Tijdschr Geneeskd. 2010; 154:A1044. View

Dodick D . Migraine. Lancet. 2018; 391(10127):1315-1330. DOI: 10.1016/S0140-6736(18)30478-1. View

Ho T, Edvinsson L, Goadsby P . CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010; 6(10):573-82. DOI: 10.1038/nrneurol.2010.127. View

Tietjen G, Peterlin B, Brandes J, Hafeez F, Hutchinson S, Martin V . Depression and anxiety: effect on the migraine-obesity relationship. Headache. 2007; 47(6):866-75. DOI: 10.1111/j.1526-4610.2007.00810.x. View

Gasparini C, Smith R, Griffiths L . Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J Headache Pain. 2017; 18(1):20. PMC: 5307402. DOI: 10.1186/s10194-016-0711-0. View

. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

Lanteri-Minet M, Radat F, Chautard M, Lucas C . Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain. 2005; 118(3):319-326. DOI: 10.1016/j.pain.2005.09.010. View

Yang Y, Zhao H, Boomsma D, Ligthart L, Belin A, Davey Smith G . Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet. 2018; 26(8):1202-1216. PMC: 6057914. DOI: 10.1038/s41431-018-0150-2. View

10.

Curone M, Tullo V, Savino M, Proietti-Cecchini A, Bussone G, DAmico D . Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder. Neurol Sci. 2013; 34 Suppl 1:S175-7. DOI: 10.1007/s10072-013-1376-y. View

11.

Sharpe L, Dudeney J, de C Williams A, Nicholas M, McPhee I, Baillie A . Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev. 2019; 7:CD012295. PMC: 6603250. DOI: 10.1002/14651858.CD012295.pub2. View

12.

Li X, Fang Y, Gao Q, Lin E, Hu S, Ren L . A diffusion tensor magnetic resonance imaging study of corpus callosum from adult patients with migraine complicated with depressive/anxious disorder. Headache. 2010; 51(2):237-45. DOI: 10.1111/j.1526-4610.2010.01774.x. View

13.

Orlova Y, Rizzoli P, Loder E . Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018; 75(5):566-572. PMC: 5885255. DOI: 10.1001/jamaneurol.2017.5144. View

14.

Swanson S, Zeng Y, Weeks M, Colman I . The contribution of stress to the comorbidity of migraine and major depression: results from a prospective cohort study. BMJ Open. 2013; 3(3). PMC: 3612807. DOI: 10.1136/bmjopen-2012-002057. View

15.

Barbanti P, Ferroni P . Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations. J Pain Res. 2017; 10:2319-2329. PMC: 5628659. DOI: 10.2147/JPR.S113614. View

16.

Martin V, Behbehani M . Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I. Headache. 2006; 46(1):3-23. DOI: 10.1111/j.1526-4610.2006.00309.x. View

17.

Anttila V, Bulik-Sullivan B, Finucane H, Walters R, Bras J, Duncan L . Analysis of shared heritability in common disorders of the brain. Science. 2018; 360(6395). PMC: 6097237. DOI: 10.1126/science.aap8757. View

18.

Bender S, Oelkers-Ax R, Resch F, Weisbrod M . Frontal lobe involvement in the processing of meaningful auditory stimuli develops during childhood and adolescence. Neuroimage. 2006; 33(2):759-73. DOI: 10.1016/j.neuroimage.2006.07.003. View

19.

Samaan Z, Gaysina D, Cohen-Woods S, Craddock N, Jones L, Korszun A . Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol. 2011; 11:66. PMC: 3120667. DOI: 10.1186/1471-2377-11-66. View

20.

Cui Y, Kataoka Y, Watanabe Y . Role of cortical spreading depression in the pathophysiology of migraine. Neurosci Bull. 2014; 30(5):812-22. PMC: 5562594. DOI: 10.1007/s12264-014-1471-y. View